TwinBeech Capital’s Pfizer PFE Stock Holding History

TwinBeech Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$287K	Sell	10,234 -300,532	-97%	-$8M	0.03%	461
2025 Q4	$7.74M	Sell	310,766 -2,908	-0.9%	-$73.3K	0.55%	51
2025 Q3	$7.99M	Sell	313,674 -571,134	-65%	-$14.1M	0.32%	99
2025 Q2	$21.4M	Buy	+884,808	New	+$20.6M	0.49%	67
2025 Q1	–	Sell	-2,318,613	Closed	-$61.5M	–	903
2024 Q4	$61.5M	Buy	2,318,613 +1,743,849	+303%	+$47.3M	1.05%	20
2024 Q3	$16.6M	Buy	+574,764	New	+$16.8M	0.32%	89
2024 Q1	–	Sell	-1,762,164	Closed	-$50.7M	–	785
2023 Q4	$50.7M	Buy	+1,762,164	New	+$53.3M	0.82%	26
2023 Q3	–	Sell	-6,361	Closed	-$233K	–	836
2023 Q2	$233K	Buy	+6,361	New	+$248K	﹤0.01%	550
2022 Q4	–	Sell	-12,315	Closed	-$539K	–	881
2022 Q3	$539K	Buy	+12,315	New	+$598K	0.01%	518
2022 Q1	–	Sell	-36,121	Closed	-$2.13M	–	695
2021 Q4	$2.13M	Buy	36,121 +19,744	+121%	+$978K	0.12%	222
2021 Q3	$704K	Buy	16,377 +284	+2%	+$12.6K	0.05%	380
2021 Q2	$630K	Sell	16,093 -9,095	-36%	-$354K	0.08%	278
2021 Q1	$913K	Buy	+25,188	New	+$894K	0.13%	205

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

TwinBeech Capital's PFE Position: Q1 2026 in Review

TwinBeech Capital reduced its Pfizer (PFE) stake by 97% in Q1 2026, selling an estimated $8M and leaving 10,234 shares worth $287K. The position accounts for 0.03% of the portfolio, ranked #461.

TwinBeech Capital first reported a position in PFE in Q1 2021 and has held it in 13 quarters since. The position peaked at $61.5M in Q4 2024. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

TwinBeech Capital held 10,234 shares of Pfizer worth $287K as of Q1 2026.
TwinBeech Capital sold 300,532 Pfizer shares in Q1 2026, an estimated $8M.
Pfizer made up 0.03% of TwinBeech Capital's portfolio in Q1 2026, its #461 holding.
TwinBeech Capital first reported a position in Pfizer in Q1 2021 and has held it in 13 quarters since.
TwinBeech Capital's Pfizer position peaked at $61.5M in Q4 2024.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on TwinBeech Capital's 13F filing for Q1 2026, filed 15 May 2026.